These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 11435337)

  • 1. Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial.
    Ammirati F; Colivicchi F; Santini M;
    Circulation; 2001 Jul; 104(1):52-7. PubMed ID: 11435337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope.
    Connolly SJ; Sheldon R; Roberts RS; Gent M
    J Am Coll Cardiol; 1999 Jan; 33(1):16-20. PubMed ID: 9935002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators.
    Sutton R; Brignole M; Menozzi C; Raviele A; Alboni P; Giani P; Moya A
    Circulation; 2000 Jul; 102(3):294-9. PubMed ID: 10899092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDD pacing with rate drop response function versus DDI with rate hysteresis pacing for cardioinhibitory vasovagal syncope.
    Ammirati F; Colivicchi F; Toscano S; Pandozi C; Laudadio MT; De Seta F; Santini M
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2178-81. PubMed ID: 9825314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE).
    Raviele A; Giada F; Menozzi C; Speca G; Orazi S; Gasparini G; Sutton R; Brignole M;
    Eur Heart J; 2004 Oct; 25(19):1741-8. PubMed ID: 15451153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope.
    Sheldon R; Koshman ML; Wilson W; Kieser T; Rose S
    Am J Cardiol; 1998 Jan; 81(2):158-62. PubMed ID: 9591898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Chamber Pacing With Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope: The SPAIN Study.
    Baron-Esquivias G; Morillo CA; Moya-Mitjans A; Martinez-Alday J; Ruiz-Granell R; Lacunza-Ruiz J; Garcia-Civera R; Gutierrez-Carretero E; Romero-Garrido R
    J Am Coll Cardiol; 2017 Oct; 70(14):1720-1728. PubMed ID: 28958328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DDDR closed loop stimulation for the prevention of vasovagal syncope: results from the INVASY prospective feasibility registry.
    Occhetta E; Bortnik M; Vassanelli C;
    Europace; 2003 Apr; 5(2):153-62. PubMed ID: 12633640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of dual-chamber pacing with Closed Loop Stimulation in tilt-induced cardio-inhibitory reflex syncope (BIOSync trial): study protocol for a randomized controlled trial.
    Brignole M; Tomaino M; Aerts A; Ammirati F; Ayala-Paredes FA; Deharo JC; Del Rosso A; Hamdan MH; Lunati M; Moya A; Gargaro A;
    Trials; 2017 May; 18(1):208. PubMed ID: 28472974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.
    Connolly SJ; Sheldon R; Thorpe KE; Roberts RS; Ellenbogen KA; Wilkoff BL; Morillo C; Gent M;
    JAMA; 2003 May; 289(17):2224-9. PubMed ID: 12734133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vasovagal Syncope and pacing (Synpace) trial: rationale and study design.
    Raviele A; Giada F; Sutton R; Alboni P; Brignole M; Del Rosso A; Di Girolamo E; Luise R; Menozzi C
    Europace; 2001 Oct; 3(4):336-41. PubMed ID: 11678394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does cardiac pacing reduce syncopal recurrences in cardioinhibitory vasovagal syncope patients selected with head-up tilt test? Analysis of a 5-year follow-up database.
    Russo V; Rago A; De Rosa M; Papa AA; Simova I; Petrov I; Bonev N; Gargaro A; Golino P; Nigro G
    Int J Cardiol; 2018 Nov; 270():149-153. PubMed ID: 29980368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closed-loop cardiac pacing vs. conventional dual-chamber pacing with specialized sensing and pacing algorithms for syncope prevention in patients with refractory vasovagal syncope: results of a long-term follow-up.
    Palmisano P; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2012 Jul; 14(7):1038-43. PubMed ID: 22247273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Closed loop stimulation in prevention of vasovagal syncope. Inotropy Controlled Pacing in Vasovagal Syncope (INVASY): a multicentre randomized, single blind, controlled study.
    Occhetta E; Bortnik M; Audoglio R; Vassanelli C;
    Europace; 2004 Nov; 6(6):538-47. PubMed ID: 15519257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of closed-loop stimulation vs. DDD pacing on haemodynamic variations and occurrence of syncope induced by head-up tilt test in older patients with refractory cardioinhibitory vasovagal syncope: the Tilt test-Induced REsponse in Closed-loop Stimulation multicentre, prospective, single blind, randomized study.
    Palmisano P; Dell'Era G; Russo V; Zaccaria M; Mangia R; Bortnik M; De Vecchi F; Giubertoni A; Patti F; Magnani A; Nigro G; Rago A; Occhetta E; Accogli M
    Europace; 2018 May; 20(5):859-866. PubMed ID: 28407148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study.
    Madrid AH; Ortega J; Rebollo JG; Manzano JG; Segovia JG; Sánchez A; Peña G; Moro C
    J Am Coll Cardiol; 2001 Feb; 37(2):554-9. PubMed ID: 11216978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second Vasovagal Pacemaker Study (VPS II): rationale, design, results, and implications for practice and future clinical trials.
    Sheldon R; Connolly S;
    Card Electrophysiol Rev; 2003 Dec; 7(4):411-5. PubMed ID: 15071266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study.
    Raviele A; Brignole M; Sutton R; Alboni P; Giani P; Menozzi C; Moya A
    Circulation; 1999 Mar; 99(11):1452-7. PubMed ID: 10086969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. The International Rate-Drop Investigators Group.
    Benditt DG; Sutton R; Gammage MD; Markowitz T; Gorski J; Nygaard GA; Fetter J
    Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 2):832-9. PubMed ID: 9080522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permanent cardiac pacing to prevent vasovagal syncope.
    Raj SR; Sheldon RS
    Curr Opin Cardiol; 2002 Jan; 17(1):90-5. PubMed ID: 11790939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.